Most investors recognize Johnson
& Johnson (NYSE: JNJ ) as a consumer health care products
company, since that segment -- which produces Tylenol, Band-Aids, Listerine,
and Neutrogena -- is the most visible of its three businesses. However,
J&J's consumer health care segment is actually smaller than its other two
business divisions: pharmaceuticals and medical devices and diagnostics.
In this article, I will discuss the growth trajectory of J&J's medical devices and diagnostics business, its largest unit, which accounted for 41% of the company's 2012 revenue. The segment is a much diversified one.
In this article, I will discuss the growth trajectory of J&J's medical devices and diagnostics business, its largest unit, which accounted for 41% of the company's 2012 revenue. The segment is a much diversified one.
Analyzing the medical devices and
diagnostics business
The medical devices business is currently J&J's second fastest growing business segment. Let's take a look at how it fared compared to the pharmaceuticals and consumer health care segment's last quarter.
The medical devices business is currently J&J's second fastest growing business segment. Let's take a look at how it fared compared to the pharmaceuticals and consumer health care segment's last quarter.
|
Business Segment
|
Revenue
|
Growth (YOY)
|
Percentage of Total Revenue
|
|
Medical Devices & Diagnostics
|
$7.2 billion
|
9.6%
|
40%
|
|
Pharmaceuticals
|
$7.0 billion
|
11.7%
|
39%
|
|
Consumer Healthcare
|
$3.7 billion
|
1.1%
|
21%
|
No comments:
Post a Comment